The Ramblings of a Tattooed Mother

I am a 22 year old wife and mother, studying to be a nurse. I am young, tattooed, and other than that your stereotypical mother/housewife.

??

motivationstationforme:

I had a small panic with some brown discharge yesterday? None today but it made me really really nervous and worry and now I’m all :S…. Is this normal?

I also had my first real wave of nausea hit me this morning. Now I can smell the vomit cause it came out my nose. yuck.

I’m 5wks,3days.

I had the same thing at about 8 weeks my doctor said it common and brown discharge is usually old blood from implantation, it should be fine since it stop an wasn’t bright red :)

gorogoroiu:

i-choose-fit:

fightblr:

flaming-scrotum:

muggleland:

the ceo of abercrombie and fitch has a lot of nerve saying that ugly people shouldn’t wear his clothes when he looks like an albino orc from the lord of the rings

image

image

fashion

Now is the time to reblog this.
I’ve been awaiting this picture.

Hahaha I can’t help it. The irony.

I’ve always hated the abercombrie brand anyway.

(via idjitdalekinadeerstalker)

pubhealth: The radically simple Uniject™ injection system Rethinking the needle to extend the reach of lifesaving vaccines and medications What if syringes were so easy to use that even untrained health workers could give injections without the risk of error? What if vaccines for developing countries could be prepackaged in low-cost prefilled syringes, vastly reducing the amount of vaccine wasted? What if syringes could not be reused—and we knew for certain that gateway to HIV transmission was closed? The Uniject™ autodisable injection system (Uniject), born in PATH’s Seattle shop, is little more than a small bubble of plastic attached to a needle, but it answers all these needs. It is so simple that health workers can learn to use it after less than two hours of training. It cannot be reused, which eliminates one route of disease transmission. And it is precisely prefilled by the pharmaceutical producers with a single dose, which ensures that the correct amount of drug is delivered and that none is discarded unnecessarily. PATH developed Uniject with funding from the US Agency for International Development and then licensed the system to BD, the largest syringe manufacturer in the world. As part of the licensing agreement, BD supplies the Uniject system to pharmaceutical producers at preferential prices for use in developing-country programs. Developing Uniject and bringing it to market has been a 20-year endeavor. Originally developed for use with vaccines, Uniject now promises to extend the reach of other lifesaving drugs as well as contraception. Uniject is a trademark of BD. (From PATH) http://www.path.org/our-work/uniject.php

pubhealth:

The radically simple Uniject™ injection system Rethinking the needle to extend the reach of lifesaving vaccines and medications

What if syringes were so easy to use that even untrained health workers could give injections without the risk of error?

What if vaccines for developing countries could be prepackaged in low-cost prefilled syringes, vastly reducing the amount of vaccine wasted?

What if syringes could not be reused—and we knew for certain that gateway to HIV transmission was closed?

The Uniject™ autodisable injection system (Uniject), born in PATH’s Seattle shop, is little more than a small bubble of plastic attached to a needle, but it answers all these needs. It is so simple that health workers can learn to use it after less than two hours of training. It cannot be reused, which eliminates one route of disease transmission. And it is precisely prefilled by the pharmaceutical producers with a single dose, which ensures that the correct amount of drug is delivered and that none is discarded unnecessarily.

PATH developed Uniject with funding from the US Agency for International Development and then licensed the system to BD, the largest syringe manufacturer in the world. As part of the licensing agreement, BD supplies the Uniject system to pharmaceutical producers at preferential prices for use in developing-country programs. Developing Uniject and bringing it to market has been a 20-year endeavor.

Originally developed for use with vaccines, Uniject now promises to extend the reach of other lifesaving drugs as well as contraception.

Uniject is a trademark of BD.

(From PATH)

http://www.path.org/our-work/uniject.php

(via defibrillated)